INHIBITORS OF AKT ACTIVITY

The present invention is directed to compounds which contain substituted napthyridines which inhibit the activity of Akt, a serine/threonine protein kinase. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for treating cancer c...

Full description

Saved in:
Bibliographic Details
Main Authors HARTNETT, JOHN C, EASTMAN, BRIAN W, WU, ZHICAI, NEILSON, LOU ANNE, COSFORD, NICHOLAS D. P, BILODEAU, MARK T, HU, ESSA H, TEHRANI, LIDA R, MANLEY, PETER J, CHEN, CHIXU
Format Patent
LanguageEnglish
French
Published 27.10.2005
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention is directed to compounds which contain substituted napthyridines which inhibit the activity of Akt, a serine/threonine protein kinase. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for treating cancer comprising administration of the compounds of the invention.
Bibliography:Application Number: CA20052561315